In an important step that enhances Qatar’s position in the field of health innovation, the Hamad Medical Corporation Laboratory Administration in Qatar announced the start of a full Xcoming sequence examination (WES) to detect genetic mutations responsible for diseases, to open new horizons to accurate genetic diagnosis and advanced personal treatment, where patients in Qatar can obtain faster and more accurate diagnoses, and treatment plans designed according to the genetic composition of each individual.
The Hamad Medical Corporation said – in a statement of Al -Jazeera health on the health of the enthusiasm – that conducting this advanced examination benefit from patients with genetic diseases from adults and children, and patients with certain types of cancer, as they were sending blood samples for these patients abroad to conduct the required tests that take a long time to obtain results.
The full xom sequence technique is an advanced tool for detecting genetic mutations responsible for diseases, focusing on the parts of the DNA responsible for coding proteins, where the majority of pathogens are located. Thus, it becomes a qualitative shift in the diagnosis of genetic diseases that are difficult to determine their causes, identify potential health risks, and give families a clearer vision of their medical conditions.
The examination mechanism is to collect a blood sample from the patient, then extract DNA, and the analysis of Xcom using advanced techniques, after which the data is interpreted by advanced computer programs capable of identifying the possible genetic causes of the disease.
On this occasion, Dr. Enas Abdulaziz Al -Kuwari, Head of Medical Laboratory and Pathology Department at Hamad Medical Corporation, said: “The start of a full Xcom sequence examination reflects our firm commitment to merge genetic medicine into the health care system. Through the use of advanced sequence techniques, we will be able to provide accurate and rapid diagnoses, which will make a major shift in dealing with genetic diseases in Qatar, and our doctors will be able to From providing advanced health care in line with the privacy of the genetic composition of each patient.
Dr. Enas Al -Kuwari added, “Genetic medicine has become part of our daily health care in Qatar, and with the start of a full xi sequence examination we did not need to send samples of our patients abroad, but we have become the advanced diagnoses here in our home Exact medicine and a high -level healthy and human system at the same time.
Leadership in genomic medicine
The molecular genetics laboratories of the Diagnostic Genome Department in the management of Hamad Medical Corporation laboratories are responsible for carrying out this advanced examination, under the supervision of Dr. Moza Khalifa Al -Kuwari with a specialized team of national competencies. All work steps have been approved according to the finest international standards such as the American College of Medical Genetics and Jereum (ACMG) and the American College of Pathology (CAP).
The laboratories also strengthened their infrastructure through large investments in high -capacity safe servers, advanced computing, and cyber security at the highest level, to ensure data protection and accelerate the analysis of the results provided. The introduction of this advanced examination will also help reduce patient samples abroad for a genetic examination.
Supporting the National Health Strategy
The start of the Exomial Sequence Examination is in line with the National Health Strategy and Qatar National Vision in promoting medical innovation and upgrading health care. The full oxom sequence contributes to early detection of diseases and prevention and the development of individual treatment plans, which is directly reflected in improving therapeutic results and raising the level of quality of life for citizens and residents in the State of Qatar.
In this context, Dr. Moza Al -Kuwari said: “Today our patients and their families are able to reach one of the most recent diagnostic tools in the world. This examination will shorten the diagnostic journey, and enable doctors to make accurate therapeutic decisions in a faster time, ensuring a more effective and human treatment.”
Since its foundation in 2001, the Molecular Genetic Laboratory is one of the most advanced laboratories in the region, where approximately 30,000 genetic tests are conducted annually, and supports major national programs such as pre -marriage and newborn examination. The laboratory has obtained the accreditation of the American College of Pathology (CAP) since 2014, maintaining the highest international quality levels.
The start of the Examination of the Exoding Sequencies is established as the position of Hamad Medical Corporation as an advanced regional center in the field of genomic medicine, and provides more innovative health care, while strengthening the medical infrastructure system in the State of Qatar.